Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2026-02-25 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Please find enclosed outcome of the Borad meeting for: 1. Audited Financial Results and Statements for the Quarter and Financial Year ended 31st December 2025. 2. Final dividend of ? ....
Regulatory Filings
2026-02-25 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details an order issued by a tax authority regarding a tax demand against the company. The document is a notification of a regulatory or compliance event rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management analysis. The document length is short (3153 characters) and it serves as an announcement of a regulatory development. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-20 English
Please find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details an order issued by a tax authority regarding a tax demand against the company for a specific fiscal year. The document includes the nature of the order, dates, and the company's intended response (appeal). It does not contain financial statements, earnings data, or detailed management discussion. It is a regulatory announcement about a legal/tax matter affecting the company, fitting the category of Regulatory Filings (RNS) as it is a compliance disclosure under SEBI regulations and does not fit other more specific categories like Legal Proceedings Report (LTR) because it is a tax order disclosure rather than a lawsuit update. The document length is short (3153 characters), and it is not an announcement of a report but a direct disclosure. Therefore, the best classification is Regulatory Filings (RNS).
2026-02-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) informing about an upcoming investor/analysts call scheduled for 26th February 2026. The call is to discuss the Audited Financial Results and Statements for the quarter and year ended 31st December 2025. The document provides details about the date, time, dial-in numbers, and webcast registration for the call. It does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of an event (investor/analysts call) related to financial results, not the results or report itself. Therefore, this document fits the category of a Call Transcript announcement or invitation. However, since it is only an intimation of the call and not the transcript itself, the best fitting category is Call Transcript (CT) as it relates to the call event. Confidence is high given the clear description and regulatory reference to SEBI LODR Regulation 30, which mandates such disclosures.
2026-02-19 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold an investor/analysts call for ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about an upcoming investor/analysts call scheduled for 26th February 2026. The call is to discuss the Audited Financial Results and Statements for the quarter and year ended 31st December 2025. The document includes dial-in details and webcast information for the call. It does not contain any actual financial data or detailed financial statements but is an announcement of the event where such information will be discussed. The document length is 2793 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript (CT) announcement or an Investor Presentation (IP) announcement. However, since it is specifically about an investor/analysts call, and not the transcript itself, it is an announcement of the call. The closest fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the call, but given the options, the best fit is Call Transcript (CT) as it relates to the call event. However, since the document is only an intimation of the call and not the transcript, the correct classification is Regulatory Filings (RNS).
2026-02-19 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-02-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.